Have a personal or library account? Click to login
Imaging Findings of Bisphosphonates-Associated Osteonecrosis of Jaw: Literature Review and Report of 3 Cases Cover

Imaging Findings of Bisphosphonates-Associated Osteonecrosis of Jaw: Literature Review and Report of 3 Cases

Open Access
|Feb 2016

References

  1. 1. Hamada H, Matsuo A, Koizumi T, Satomi T, Chikazu D. A simple evaluation method for early detection of bisphosphonaterelated osteonecrosis of the mandible using computed tomography. Journal of Cranio-Maxillo- Facial Surgery.2014:1-5.10.1016/j.jcms.2014.01.012
  2. 2. Malden N, Pai AY. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. British Dental Journal. 2007;203(2):93-96.10.1038/bdj.2007.636
  3. 3. Graham R, Russell G. Bisphosphonates: Mode of Action and Pharmacology. Pediatrics, 2007;119 (suppl. 2):150-162.10.1542/peds.2006-2023H
  4. 4. Yamashita J, McCauley LK. Antiresorptives and Osteonecrosis of the Jaw. J Evid Base Dent Pract. 2012;S1:233-247.10.1016/S1532-3382(12)70046-5
  5. 5. Sharma D, Ivanovski S, Slevin M, et al. Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascular Cell. 2013;5(1):1-8.10.1186/2045-824X-5-1360631223316704
  6. 6. Petcu EP, Ivanovski S, Wright RG, Slevin M, Miroiu R, Brinzaniuc K. Bisphosphonate-related osteonecrosis of jaw (BRONJ): an antiangiogenic side-effect? Diagnostic Pathology. 2012;7(78):1-3.10.1186/1746-1596-7-78347902722770117
  7. 7. Sarasquete ME, Gonzalez M, San Miguel JF, Garcıa-Sanz R. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors. Oral Dis. 2009;15:382-387.10.1111/j.1601-0825.2009.01568.x19413677
  8. 8. Arce K, Assael LA, Weissman JL, Markiewicz MR. Imaging Findings in Bisphosphonate-Related Osteonecrosis of Jaws. American Association of Oral and Maxillofacial Surgeons. 2009:76-78.10.1016/j.joms.2008.12.00219371818
  9. 9. Ferrara F, Califano L. Current perspectives in the management of patients with drug-induced osteonecrosis of the maxilla: experience of the school of Naples. BMC Geriatrics. 2010;10(supl.10):A56.10.1186/1471-2318-10-S1-A56
  10. 10. Torres SR, Chen CSK, Leroux BG, Lee PP, Hollender LG, Schubert MM. Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis. Dentomaxillofacial Radiology. 2011;40:501-505.10.1259/dmfr/14636637352815622065799
  11. 11. Stockmann P, Hinkmann FM, Lell MM, et al. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Invest. 2010;14:311-317.10.1007/s00784-009-0293-119513765
  12. 12. Otto S, Sotlar K, Ehrenfeld M, Pautke C. Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report. J Med Case Rep. 2011 Sep 23;5:47710.1186/1752-1947-5-477319510621943059
  13. 13. Vogt-Ferrier NB, Hugentobler M, Uebelhart B, Tramèr M, Rollason V. Interventions for treating osteonecrosis of the jaw bones associated with bisphosphonates (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD008455. DOI: 10.1002/14651858.CD008455.10.1002/14651858.CD008455
  14. 14. Wong YK. Bisphosphonate-related osteonecrosis of the jaws - Report of 2 cases and strategies on prevention and management. Quintessence Int. 2008 Mar;39(3):195-201.
  15. 15. Agrillo A, Filiaci F, Ramieri V, et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. European Review for Medical and Pharmacological Sciences. 2012;16:1741-1747.
  16. 16. Boeddinghaus R, Whyte A. Current concepts in maxillofacial imaging. European Journal of Radiology. 2008;66:396.10.1016/j.ejrad.2007.11.01918082349
  17. 17. Torres SR, Chen CSK, Leroux BG, Lee PP, Hollender LG, Schubert MM. Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis. Dentomaxillofacial Radiology. 2011;40:504.10.1259/dmfr/14636637352815622065799
  18. 18. Conte-Neto N, Bastos AS, Marcantonio RA, Junior EM. Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonaterelated osteonecrosis of the jaws. Head Face Med. 2012 Mar 1;8:5.10.1186/1746-160X-8-5331385522376948
  19. 19. Sanna G, L Preda, R Bruschini, et al. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Annals of Oncology. 2006;17:1512-1516.10.1093/annonc/mdl16316936182
  20. 20. del Castillo Pardo de Vera JL, García de Marcos JA, Rodríguez SA, Arenas MG, Calderón Polanco J. Osteonecrosis de los maxilares asociada al empleo de bifosfonatos Bisphosphonate-associated osteonecrosis of the jaw. Rev Esp Cir Oral y Maxilofac. 2007;29(5):295-308.
  21. 21. Wilde F, Heufelder M, Lorenz K, et al. MSCS, Rostock. Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw. december 2012;114(6):805.10.1016/j.oooo.2012.08.45823159120
  22. 22. Treister N, Sheehy N, Bae EH, Friedland B, Lerman M, Woo S. Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Diseases. 2009;15:90-91. 10.1111/j.1601-0825.2008.01494.x18992020
DOI: https://doi.org/10.1515/amma-2015-0081 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 130 - 134
Submitted on: Dec 8, 2015
|
Accepted on: Jun 4, 2015
|
Published on: Feb 9, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Adela Cristina Lazar, Mihaela Hedesiu, Aranka Ilea, Grigore Baciut, Mariana Pacurar, Radu-Septimiu Campian, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.